These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28597734)

  • 1. Platelets and cardiovascular risk.
    Renga B; Scavizzi F
    Acta Cardiol; 2017 Feb; 72(1):2-8. PubMed ID: 28597734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy.
    Christie DJ; Kottke-Marchant K; Gorman RT
    Platelets; 2008 Mar; 19(2):104-10. PubMed ID: 17852773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet activity and cardiovascular risk in apparently healthy individuals: a review of the data.
    Sharma G; Berger JS
    J Thromb Thrombolysis; 2011 Aug; 32(2):201-8. PubMed ID: 21562837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin exposure reveals novel genes associated with platelet function and cardiovascular events.
    Voora D; Cyr D; Lucas J; Chi JT; Dungan J; McCaffrey TA; Katz R; Newby LK; Kraus WE; Becker RC; Ortel TL; Ginsburg GS
    J Am Coll Cardiol; 2013 Oct; 62(14):1267-1276. PubMed ID: 23831034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet Function in Cardiovascular Disease: Activation of Molecules and Activation by Molecules.
    Khodadi E
    Cardiovasc Toxicol; 2020 Feb; 20(1):1-10. PubMed ID: 31784932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets volume indexes and cardiovascular risk factors.
    Batista TR; Figueiredo RC; Rios DRA
    Rev Assoc Med Bras (1992); 2018 Jun; 64(6):554-559. PubMed ID: 30304315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G
    Expert Opin Pharmacother; 2015; 16(12):1739-47. PubMed ID: 26067422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets and vascular risk: an option for treatment.
    Jagroop IA; Kakafika AI; Mikhailidis DP
    Curr Pharm Des; 2007; 13(16):1669-83. PubMed ID: 17584097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet volume indices are associated with systolic and diastolic cardiac dysfunction, and left ventricular hypertrophy.
    Fujita S; Takeda Y; Kizawa S; Ito T; Sakane K; Ikemoto T; Okada Y; Sohmiya K; Hoshiga M; Ishizaka N
    BMC Cardiovasc Disord; 2015 Jun; 15():52. PubMed ID: 26077978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of mean platelet volume on short- and long-term outcomes among patients with non-ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: A single-center large observational study.
    Wasilewski J; Desperak P; Hawranek M; Ciślak A; Osadnik T; Pyka Ł; Gawlita M; Bujak K; Niedziela J; Krawczyk M; Gąsior M
    Platelets; 2016 Jul; 27(5):452-8. PubMed ID: 26939525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mean platelet volume measurements should not be used as an indicator of platelet function.
    Beyan C; Beyan E
    Acta Cardiol; 2018 Feb; 73(1):107. PubMed ID: 28699842
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelets and cardiovascular disease.
    Willoughby S; Holmes A; Loscalzo J
    Eur J Cardiovasc Nurs; 2002 Dec; 1(4):273-88. PubMed ID: 14622657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet function testing as a biomarker for efficacy of antiplatelet drugs.
    Lordkipanidzé M; So D; Tanguay JF
    Biomark Med; 2016 Aug; 10(8):903-18. PubMed ID: 27414976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets in atherothrombosis.
    Vorchheimer DA; Becker R
    Mayo Clin Proc; 2006 Jan; 81(1):59-68. PubMed ID: 16438480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet Signaling Pathways and New Inhibitors.
    Grover SP; Bergmeier W; Mackman N
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):e28-e35. PubMed ID: 29563117
    [No Abstract]   [Full Text] [Related]  

  • 17. The platelet in diabetes: focus on prevention of ischemic events.
    Colwell JA; Nesto RW
    Diabetes Care; 2003 Jul; 26(7):2181-8. PubMed ID: 12832332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets as therapeutic targets to prevent atherosclerosis.
    Nording H; Baron L; Langer HF
    Atherosclerosis; 2020 Aug; 307():97-108. PubMed ID: 32653088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombocyte inhibitors in cardiovascular therapy].
    Lüscher TF; Pfisterer M
    Schweiz Rundsch Med Prax; 1990 Sep; 79(39):1132-41. PubMed ID: 2218249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
    Chung I; Choudhury A; Patel J; Lip GY
    Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.